Summary
Acute pulmonary edema, evidenced by increased lung/body weight ratios, was evoked in rats within 5 min following the intravenous injection of 16–40 μg/kg of adrenaline. This change was accompanied by a decrease of 40% of circulatory kininogen not due to generalized plasma protein loss. Rats treated 10–20 min prior to adrenaline with 10 mg/kg of acetylsalicylate (Aspirin®), 1000 KIU/kg of Kunitz anti-protease (Trasylol®), or 10 mg/kg of soybean trypsin inhibitor (SBTI), failed to exhibit pulmonary edema or decreased plasma kininogen levels, but were as sensitive as untreated animals to the arterial hypertensive effect of adrenaline. 4.8 μg/kg of carbamylcholine administered together with 40 μg/kg of adrenaline, prevented pulmonary edema. Carbamylcholine did not reduce plasma kininogen consumption by adrenaline, but effectively decreased the raised systolic arterial blood pressure, the increased systolic-diastolic pressure interval as well as the reflex slowing of the heart presented by adrenaline-treated rats. It seems that in the adrenaline-treated rat, pulmonary edema results from the joined action of vasopressor effects leading to hydrostatically forced outflow of vascular fluid, and of kinin release leading to increased peripheral vascular permeability.
Similar content being viewed by others
References
Böhm, G. M.: Vascular permeability changes during experimentally produced pulmonary edema in rats. J. Path. Bact. 92, 151–161 (1966)
Castania, A., Rothschild, A. M.: Lowering of kininogen in rat blood by adrenaline. Inhibition by sympatholytic agents, heparin and aspirin. Brit. J. Pharmacol. 50, 375–383 (1974)
Diniz, C. R., Carvalho, I. F.: A micro-method for determination of bradykininogen under several conditions. Ann. N. Y. Acad. Sci. 104, 77–89 (1963)
Eisen, V., Loveday, C.: In vivo effect of cellulose sulphate on plasma kininogen, complement and inflammation. Brit. J. Pharmacol. 42, 383–392 (1971)
Erdös, E. G.: Effect of non-steroidal anti-inflammatory drugs in endotoxin shock. Biochem. Pharmacol., Suppl. 283–291 (1968)
Ersoz, N., Finestone, S. C.: Adrenaline-induced pulmonary edema and its treatment. Brit. J. Anaesth. 43, 709–712 (1971)
Ferreira, S. H., Moncada, S., Vane, J. R.: Indomethacin and aspirin abolish prostaglandin release from the spleen. Nature New Biol. 231, 237–241 (1971)
Ferreira, S. H., Vane, J. R.: New aspects of the mode of action of non-steroid anti-inflammatory drugs. Ann. Rev. Pharmacol. 14, 57–73 (1974)
Gomes, J. C.: Edema pulmonar adrenalínico em cobaias: sua relação com neo-formacão de possíveis mediadores. Master of Science Dissertation, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, 14100, Brazil 1976
Katori, M., Mineshita, S., Shigei, T.: Depletion of Kininogen I by stem bromelain and its significance in prevention of adrenaline-induced pulmonary edema in rats. Advanc. exp. Med. Biol. 8, 273–292 (1970)
Oliveira Antonio, M. P.: Inter-relação catecolaminas-histamina no mastócito e no edema pulmonar no rato. Doctoral Dissertation, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, 14 100, Brazil 1973
Reichgott, M. J., Engelman, K.: Indomethacin: lack of effect on lethality of endotoxin in rats. Circulat. Shock 2, 215–219 (1975)
Rothschild, A. M.: Some pharmacodynamic properties of cellulose sulphate, a kininogen-depleting agent in the rat. Brit. J. Pharmacol. 33, 501–512 (1968)
Rothschild, A. M., Castania, A., Cordeiro, R. S. B.: Consumption of kininogen, formation of kinin and activation of arginine ester hydrolase in rat plasma by rat peritoneal fluid cells in the presence of l-adrenaline. Specific sensitivity to acetylsalicylic acid. Naunyn-Schmiedeberg's Arch. Pharmacol. 285, 243–256 (1974b)
Rothschild, A. M., Cordeiro, R. S. B., Castania, A.: Lowering of kininogen in rat blood by catecholamines. Involvement of noneosinophil granulocytes and selective inhibition by Trasylol. Naunyn-Schmiedeberg's Arch. Pharmacol. 282, 323–327 (1974a)
Rothschild, A. M., Cordeiro, R. S. B., Castania, A.: Acute pulmonary edema and plasma kininogen consumption in the adrenaline-treated rat: inhibition by acetylsalicylate and resistance to salicylate and indomethacin. Naunyn-Schmiedeberg's Arch. Pharmacol. 288, 319–321 (1975)
Rothschild, A. M., Gomes, J. C., Castania, A.: Adrenergic and cholinergic control of the activation of the kallikrein-kinin system in rat blood. Advanc. exp. Med. Biol. 70, 197–200 (1976)
Staub, N. C.: Pulmonary edema. Physiol. Rev. 54, 678–811 (1974)
Stürmer, E., Cerletti, A.: Das Bradykinin-Ödem der Rattenpfote. Helv. physiol. pharmacol. Acta 19, C 32–34 (1961)
Sykes, J. A. C., Maddox, I. S.: Prostaglandin production by experimental tumors; effects of anti-inflammatory compounds. Nature New Biol. 23, 59–61 (1972)
Visscher, M. B., Haddy, F. J., Stephens, G.: The physiology and pharmacology of the lung edema. Pharmacol. Rev. 8, 389–434 (1956)
Vogel, R., Werle, E.: Kallikrein inhibitors. In: Handbook of Experimental Pharmacology, vol. 25 (E. Erdös, ed.), pp. 213–249. Berlin-Heidelberg-New York: Springer 1970
Welch, W. H.: Zur Pathologie des Lungenödems. Virchows Arch. 72, 375–412 (1878)
Werle, E., Zach, P.: Verteilung von Kininogen in Serum und Geweben bei Ratten und anderen Säugetieren. Z. Klin. Chem. Klin. Biochem. 8, 186–189 (1970)
Wilhelm, D. L.: The mediation of increased vascular permeability in inflammation. Pharmacol. Rev. 14, 251–280 (1962)
Author information
Authors and Affiliations
Additional information
Supported in part by Fundação de Amparo à Pesquisa do Estado de São Paulo, Grant 73/685
Rights and permissions
About this article
Cite this article
Rothschild, A.M., Castania, A. Contribution of vasopressor and plasma kininogen changes towards acute adrenaline pulmonary edema in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 295, 177–181 (1976). https://doi.org/10.1007/BF00499452
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00499452